SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-066352
Filing Date
2019-11-22
Accepted
2019-11-21 21:42:38
Documents
5
Period of Report
2019-11-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1923549-4_8k.htm 8-K 23081
2 EXHIBIT 1.1 tm1923549d4_ex1-1.htm EX-1.1 166038
3 EXHIBIT 5.1 tm1923549d4_ex5-1.htm EX-5.1 12628
4 EXHIBIT 99.1 tm1923549d4_ex99-1.htm EX-99.1 41742
5 GRAPHIC tm1923549d4_ex5-1img001.jpg GRAPHIC 20107
  Complete submission text file 0001104659-19-066352.txt   272640
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37350 | Film No.: 191238595
SIC: 3841 Surgical & Medical Instruments & Apparatus